Edward Kim

5PUBLICATIONS
9CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 04, 2024
Sotorasib with panitumumab in chemotherapy-refractory KRASG12C-mutated colorectal cancer: a phase 1b trial.

Yasutoshi Kuboki, Marwan Fakih, John Strickler

|Dec 22, 2023
NCI10066: a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and gastroesophageal junction adenocarcinoma.

Michael Cecchini, James M Cleary, Yu Shyr

|Dec 01, 2023
Phase I/II trial of BMS-986,205 and nivolumab as first line therapy in hepatocellular carcinoma.

Jasmine C Huynh, May Cho, Arta Monjazeb

|Jul 30, 2022
A phase I dose escalation, dose expansion and pharmacokinetic trial of gemcitabine and alisertib in advanced solid tumors and pancreatic cancer.

Justin A Chen, Jasmine C Huynh, Chun-Yi Wu

|Feb 08, 2020
Oxaliplatin-DNA Adducts as Predictive Biomarkers of FOLFOX Response in Colorectal Cancer: A Potential Treatment Optimization Strategy.

Maike Zimmermann, Tao Li, Thomas J Semrad

Pageof 1

Frequent Collaborators

1 joint publications

Thomas J Semrad

1 joint publications

Paul T Henderson

1 joint publications

John Strickler

1 joint publications

Rona Yaeger